Similarly, Riobello et al. analyzed a series of 125 poorly differentiated and undifferentiated carcinomas for IDH mutations and found that, irrespective of the histologic subtype, disease-specific survival was more favorable in IDH2-mutant versus wild-type cases [106]. Here, IDH2 is linked to carcinoma.